NCT04579523
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Blood Protein Disorders
Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.
3,039 public trials
566 recruiting studies
Blood Protein Disorders trial results
NCT07624513
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Not Yet Recruiting
Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging
NCT07624760
- Conditions
- AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +23 more
- Locations
-
- University Hospital Zurich Zurich, Canton of Zurich, Switzerland
NCT07623798
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- ZhongShan Hospital FuDan University Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Phase 1b/2: Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma
NCT07601100
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Not Yet Recruiting
Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma
NCT07611149
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
Not Yet Recruiting
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
NCT07609940
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Cytokine Release Syndrome, +19 more
- Locations
-
Not specified
Not Yet Recruiting
A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment
NCT07609706
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma
NCT07600151
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University Medical Center Hamburg-Eppendorf Hamburg, Germany
Not Yet Recruiting
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
NCT05976555
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified